Definitive concurrent chemoradiotherapy with paclitaxel plus carboplatin is superior to cisplatin plus 5‐fluorouracil in patients with inoperable esophageal squamous cell carcinoma using retrospective, real‐world evidence

Definitive concurrent chemoradiotherapy with paclitaxel plus carboplatin is superior to cisplatin plus 5‐fluorouracil in patients with inoperable esophageal squamous cell carcinoma using retrospective, real‐world evidence

Abstract Background The optimal definitive chemotherapy regimen during concurrent chemoradiotherapy (CRT) for patients with advanced esophageal squamous cell carcinoma (ESCC) remains unclear because of conflicting evidence. This study aimed to compare the effectiveness of taxane‐based chemotherapy w...

Full description

Saved in:
Bibliographic Details
Main Authors: Jason Chia‐Hsun Hsieh, Pin‐Chun Chiang, Tsung‐Min Hung, Yin‐Kai Chao, Yung‐Chia Kuo, Chih‐Tsung Wen, Po‐Jung Su, Meng‐Ting Peng, Huan‐Wu Chen, Hui‐Ling Liu, Hsien‐Kun Chang, Min‐Hsien Wu, Hung‐Ming Wang
Format: article
Language:EN
Published: Wiley 2021
Subjects:
5‐fluorouracil
carboplatin
cisplatin
definitive chemoradiotherapy
esophageal squamous cell carcinoma
paclitaxel
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Online Access:https://doaj.org/article/2e403fc1c54744b5988cbb4089b73642
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/2e403fc1c54744b5988cbb4089b73642

Similar Items